Menu
A screenshot of the HHS OIG's Jan. 27 bulletin on direct-to-consumer sales.
The HHS Office of Inspector General published a Jan. 27 bulletin detailing how drugmakers can take advantage of direct-to-consumer sales to patients with federal health care coverage.

HHS Releases New Guidance for Direct-to-Consumer Drug Sales

Shannon Young, Associate Editor/Senior Writer 340B Report Views
Pharmaceutical manufacturers can sell prescription drugs directly to patients—including Medicare and Medicaid enrollees—who choose to pay with cash as long [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

State Contract Pharmacy Roundup: Actions in Utah, Maine, New Mexico and Oregon

Kansas Introduces 340B Hospital Reporting Bill Amid Stalled Contract Pharmacy Legislation 

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live